Calprotectin in viral systemic infections—COVID-19 versus hepatitis C virus
Sign Up to like & getrecommendations! Published in 2021 at "Clinical and Experimental Medicine"
DOI: 10.1007/s10238-021-00743-7
Abstract: This study aims to evaluate differences in serum and fecal calprotectin in patients with HCV chronic hepatitis and COVID-19 infection and compare them to a control group. This observational study was performed between April 2020… read more here.
Keywords: medicine; serum fecal; hepatitis; infection ... See more keywords
Utility of Fecal Calprotectin in Routine Clinical Practice Is Impaired by Poor Sample Return Rates
Sign Up to like & getrecommendations! Published in 2020 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-020-06694-5
Abstract: We read with interest the study by Barsky et al. [1] reporting on patient preferences for assessment of disease activity of Inflammatory Bowel Disease (IBD) by either colonoscopy or fecal calprotectin (FC). They report an… read more here.
Keywords: sample return; clinical practice; return; return rates ... See more keywords
Effect of supplemental prebiotics, probiotics and bioactive proteins on the microbiome composition and fecal calprotectin in C57BL6/j mice.
Sign Up to like & getrecommendations! Published in 2021 at "Biochimie"
DOI: 10.1016/j.biochi.2021.02.010
Abstract: The composition and metabolic activity of the microbiome affect many aspects of health, and there is current interest in dietary constituents that may affect this system. The purpose of this study was to evaluate the… read more here.
Keywords: probiotics bioactive; bioactive proteins; mice; composition ... See more keywords
Can Fecal Calprotectin Serve as a Screen for Necrotizing Enterocolitis in Infants?
Sign Up to like & getrecommendations! Published in 2020 at "Clinical biochemistry"
DOI: 10.1016/j.clinbiochem.2020.06.015
Abstract: BACKGROUND Researchers are debating if fecal calprotectin results are useful for infant patients, especially in screening for necrotizing enterocolitis (NEC). Currently, none of the FDA-approved calprotectin assays provide cut-offs for infant patients. We retrospectively analyzed… read more here.
Keywords: cut offs; infant patients; cut; necrotizing enterocolitis ... See more keywords
Tu1745 – Correlation of Fecal Calprotectin and C-Reactive Protein Concentrations with Clinical Outcomes and Endoscopic Disease Activity in Patients with Ulcerative Colitis Receiving Induction Therapy with Etrasimod
Sign Up to like & getrecommendations! Published in 2019 at "Gastroenterology"
DOI: 10.1016/s0016-5085(19)39731-8
Abstract: 1Medical College of Wisconsin, Milwaukee, WI, USA; 2Western University, London, Ontario, Canada; 3Arena Pharmaceuticals, Inc., San Diego, CA, USA; 4Hospital Clinic of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain; 5Virginia Mason Medical Center, Seattle, WA, USA; 6University… read more here.
Keywords: fecal calprotectin; reactive protein; correlation fecal; calprotectin reactive ... See more keywords
Enteric Dysbiosis and Fecal Calprotectin Expression in Premature Infants
Sign Up to like & getrecommendations! Published in 2018 at "Pediatric research"
DOI: 10.1038/s41390-018-0254-y
Abstract: BackgroundPremature infants often develop enteric dysbiosis with a preponderance of Gammaproteobacteria, which has been related to adverse clinical outcomes. We investigated the relationship between increasing fecal Gammaproteobacteria and mucosal inflammation, measured by fecal calprotectin (FC).MethodsStool… read more here.
Keywords: dysbiosis; enteric dysbiosis; gammaproteobacteria; premature infants ... See more keywords
The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease
Sign Up to like & getrecommendations! Published in 2017 at "Scandinavian Journal of Gastroenterology"
DOI: 10.1080/00365521.2017.1315740
Abstract: Abstract Background and aims: Fecal calprotectin is an important biomarker used in the evaluation of inflammatory bowel disease. It has proven to be an effective tool in initial screening as well monitoring response to therapy.… read more here.
Keywords: inflammatory bowel; bowel disease; fecal calprotectin;
Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn's disease.
Sign Up to like & getrecommendations! Published in 2023 at "Scandinavian journal of gastroenterology"
DOI: 10.1080/00365521.2023.2194009
Abstract: BACKGROUND Response evaluation after induction therapy with ustekinumab (UST) in Crohn's disease (CD) is important for decisions on maintenance therapy. We aimed to assess the potential of fecal calprotectin (FC) levels to predict endoscopic response… read more here.
Keywords: endoscopic response; therapy; crohn disease; fecal calprotectin ... See more keywords
Fecal Calprotectin in Gastrointestinal Disease.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical chemistry"
DOI: 10.1093/clinchem/hvad051
Abstract: BACKGROUND Inflammatory bowel disease (IBD) comprises a group of chronic conditions characterized by relapsing and remitting inflammation of the gastrointestinal tract. The incidence is increasing worldwide, and the therapeutic options for management are expanding. Endoscopy… read more here.
Keywords: ibd; calprotectin gastrointestinal; gastrointestinal disease; calprotectin ... See more keywords
P101 Fecal calprotectin is increased among patients with pouchitis and increases with increasing endoscopic subscores: Real-world data from a prospectively collected database
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjab076.229
Abstract: An accurate and non-invasive surrogate marker of inflammation is needed for managing patients after Ileal pouch-anal anastomosis (IPAA). In this study, we evaluate the performance of fecal calprotectin (FC) in patients with ulcerative colitis (UC)… read more here.
Keywords: fecal calprotectin; endoscopic; endoscopic histologic; prospectively collected ... See more keywords
P539 COVID-19 is Associated with Long-term Elevated Fecal Calprotectin Levels in Patients with Crohn’s Disease but not in Ulcerative Colitis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjab232.666
Abstract: Data regarding the long-term effects of COVID-19 on patients with Inflammatory bowel disease is scarce. Fecal calprotectin (FC) correlates with IBD clinical and endoscopic activity. We compared fecal calprotectin levels between patients with COVID-19 to… read more here.
Keywords: sars cov; value; colitis; fecal calprotectin ... See more keywords